- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05705401
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer (HERO)
A Phase III Randomized Trial of Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer (HERO)
Study Overview
Status
Conditions
Detailed Description
The landmark trials that established breast conservation therapy (BCT) (breast-conserving surgery followed by adjuvant breast irradiation) as a suitable alternative to mastectomy were conducted in an era that predated biological subtyping of breast cancer and the use of HER2-directed therapies in patients with HER2+ cancers. These trials established adjuvant radiotherapy following breast-conserving surgery as necessary to maximize local control, yet, in the intervening years, overall outcomes have improved significantly owing to widespread adoption of screening mammography, resulting in a substantial reduction in average tumor size at diagnosis, as well as improvements in surgical techniques and, crucial for this proposal, the development of highly active systemic therapies.
Before the development of HER2-targeted therapies, patients with HER2-driven localized breast cancer had among the highest rates of local recurrence. However, with improved identification of these patients and the advent of HER2-directed therapies, outcomes have improved significantly, and trials have sought to optimize treatment to reduce the morbidity of both local and systemic treatment. Among the most salient of these examples is the APT trial, a single-arm adjuvant study that enrolled 410 breast cancer patients with HER2+ tumors ≤ 3cm in size and negative axillary nodes, who received adjuvant systemic therapy with weekly paclitaxel and trastuzumab for 12 weeks (TH) followed by 9 months of trastuzumab monotherapy. In addition to demonstrating a very low incidence of distant recurrence, among those on the trial who underwent BCT (lumpectomy and radiation, n = 244), only 2 local recurrence (LR) events have been reported after 7 years of follow-up (7-year LR = 1.2%), representing among the most favorable local outcomes of any breast cancer cohort studied to date. Confirmatory results are forthcoming from the ATEMPT trial, which evaluated the antibody-drug conjugate T-DM1 (ado-trastuzumab emtansine) (n=383) vs the TH regimen from the APT trial (n = 114), thus far showing only 3 LRs in each arm with a median 3-years of follow-up. Importantly, per the current standard of care for HER2+ patients undergoing BCT, all patients presumably received adjuvant breast radiotherapy.
The balance of the BCT literature, including a landmark meta-analysis by the Early Breast Cancer Trialists' Collaborative Group, suggests that adjuvant radiotherapy approximately halves the risk of local recurrence following lumpectomy across all analyzable subgroups. While the relative benefit appears constant across subgroups, the absolute benefit of adjuvant radiotherapy varies with the underlying risk. Taking the favorable results of the APT trial (1.2% 7-year LR), if one presumes that omission of radiotherapy yields a doubling or tripling of local recurrence (based on the observed RR of 0.5 - 0.66 for those receiving radiotherapy across the preponderance of historical trials), this population might have manifested a LR rate of 2.4 - 3.6% with the omission of radiotherapy. That is to say, the hypothesis is that administration of RT to APT patients undergoing BCT may have reduced the 7-year absolute risk of LR by only 1.2-2.4%. Through the identification of patients who are at low risk of LR, it may be acceptable for such patients to forego radiation. This hypothesis will be studied by evaluating omission of radiotherapy among patients with pT1N0 disease at breast-conserving surgery who receive adjuvant HER2-directed therapy (trastuzumab/paclitaxel preferred, other options per protocol), or with clinical tumors ≤ 3 cm and clinically negative axillary nodes (cN0) who achieve a pathologic complete response (pCR; ypT0N0) following preoperative (neoadjuvant) administration of HER2-directed therapy (trastuzumab/paclitaxel preferred, other options per protocol). It is expcted that the 5-year LR rate for this population omitting radiotherapy will be 2% or less, and that omission of radiation will not have a measurable impact on regional and distant recurrences or overall survival.
The practice of breast radiation oncology has benefited immensely from practice-changing trials that have refined the application of adjuvant radiotherapy since the early surgical studies determined whole breast radiotherapy to be necessary following lumpectomy. There are now several favorable breast cancer subtypes in which patients routinely forego radiotherapy after trials demonstrating modest benefits in terms of local recurrence and no impact on distant recurrence or survival, such as among small, low grade luminal cancers in older women and "good-risk" DCIS. Therefore, this will study the omission of radiotherapy among a population of HER2+ breast cancer patients who are now appreciated to also have favorable risk, so as to similarly weigh the attendant inconveniences, cost and morbidity of radiotherapy in light of an established absolute benefit, which may prove to be modest.
Study Type
Enrollment (Estimated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Norman Wolmark, MD
Study Contact Backup
- Name: Director, Department of Regulatory Affairs
- Phone Number: 412-339-5300
- Email: langerj@nrgoncology.org
Study Locations
-
-
-
Bayamon, Puerto Rico, 00959-5060
- Recruiting
- Cancer Center-Metro Medical Center Bayamon
-
Principal Investigator:
- Luis J. Santos Reyes
-
Contact:
- Site Public Contact
- Phone Number: 787-395-7085
-
Manati, Puerto Rico, 00674
- Recruiting
- Doctors Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 787-621-4397
-
Principal Investigator:
- Luis J. Santos Reyes
-
San Juan, Puerto Rico, 00927
- Recruiting
- Centro Comprensivo de Cancer de UPR
-
Principal Investigator:
- Luis J. Santos Reyes
-
Contact:
- Site Public Contact
- Phone Number: 412-339-5294
- Email: Roster@nrgoncology.org
-
San Juan, Puerto Rico, 00917
- Recruiting
- San Juan Community Oncology Group
-
Principal Investigator:
- Luis J. Santos Reyes
-
Contact:
- Site Public Contact
- Phone Number: 787-274-3387
-
San Juan, Puerto Rico, 00936
- Recruiting
- San Juan City Hospital
-
Principal Investigator:
- Luis J. Santos Reyes
-
Contact:
- Site Public Contact
- Phone Number: 787-763-1296
-
-
-
-
Arizona
-
Phoenix, Arizona, United States, 85004
- Recruiting
- Cancer Center at Saint Joseph's
-
Principal Investigator:
- Shahzad Siddique
-
Contact:
- Site Public Contact
- Phone Number: 602-406-0777
- Email: Research-cancerinstitute@dignityhealth.org
-
Tucson, Arizona, United States, 85719
- Recruiting
- Banner University Medical Center - Tucson
-
Principal Investigator:
- Lora S. Wang
-
Contact:
- Site Public Contact
- Email: UACC-IIT@uacc.arizona.edu
-
Tucson, Arizona, United States, 85719
- Recruiting
- University of Arizona Cancer Center-North Campus
-
Principal Investigator:
- Lora S. Wang
-
Contact:
- Site Public Contact
- Email: UACC-IIT@uacc.arizona.edu
-
-
California
-
Antioch, California, United States, 94531
- Recruiting
- Kaiser Permanente-Deer Valley Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Arroyo Grande, California, United States, 93420
- Recruiting
- Mission Hope Medical Oncology - Arroyo Grande
-
Principal Investigator:
- Shahzad Siddique
-
Contact:
- Site Public Contact
- Phone Number: 805-219-4673
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Auburn, California, United States, 95602
- Recruiting
- Sutter Auburn Faith Hospital
-
Principal Investigator:
- Christopher U. Jones
-
Contact:
- Site Public Contact
- Email: NCIclinicaltrials@sutterhealth.org
-
Auburn, California, United States, 95603
- Recruiting
- Sutter Cancer Centers Radiation Oncology Services-Auburn
-
Principal Investigator:
- Christopher U. Jones
-
Contact:
- Site Public Contact
- Email: NCIclinicaltrials@sutterhealth.org
-
Beverly Hills, California, United States, 90211
- Recruiting
- Tower Cancer Research Foundation
-
Contact:
- Site Public Contact
- Email: towercancerresearch@toweroncology.com
-
Principal Investigator:
- Armando E. Giuliano
-
Cameron Park, California, United States, 95682
- Recruiting
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
-
Principal Investigator:
- Christopher U. Jones
-
Contact:
- Site Public Contact
- Email: NCIclinicaltrials@sutterhealth.org
-
Duarte, California, United States, 91010
- Recruiting
- City of Hope Comprehensive Cancer Center
-
Principal Investigator:
- Jose G. Bazan
-
Contact:
- Site Public Contact
- Phone Number: 800-826-4673
- Email: becomingapatient@coh.org
-
Dublin, California, United States, 94568
- Recruiting
- Kaiser Permanente Dublin
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
-
Principal Investigator:
- Samantha A. Seaward
-
Fremont, California, United States, 94538
- Recruiting
- Kaiser Permanente-Fremont
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Fresno, California, United States, 93720
- Recruiting
- Kaiser Permanente-Fresno
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Fresno, California, United States, 93720
- Recruiting
- Fresno Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Irvine, California, United States, 92618
- Recruiting
- City of Hope at Irvine Lennar
-
Principal Investigator:
- Jose G. Bazan
-
Contact:
- Site Public Contact
- Phone Number: 877-467-3411
-
Lancaster, California, United States, 93534
- Recruiting
- City of Hope Antelope Valley
-
Principal Investigator:
- Jose G. Bazan
-
Contact:
- Site Public Contact
- Phone Number: 800-826-4673
- Email: becomingapatient@coh.org
-
Los Angeles, California, United States, 90048
- Recruiting
- Cedars Sinai Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 310-423-8965
-
Principal Investigator:
- Armando E. Giuliano
-
Los Angeles, California, United States, 90033
- Recruiting
- USC / Norris Comprehensive Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 323-865-0451
-
Principal Investigator:
- Jason C. Ye
-
Los Angeles, California, United States, 90033
- Recruiting
- Los Angeles General Medical Center
-
Principal Investigator:
- Jason C. Ye
-
Contact:
- Site Public Contact
- Phone Number: 323-865-0451
- Email: uscnorrisinfo@med.usc.edu
-
Modesto, California, United States, 95355
- Recruiting
- Memorial Medical Center
-
Principal Investigator:
- Christopher U. Jones
-
Contact:
- Site Public Contact
- Email: NCIclinicaltrials@sutterhealth.org
-
Modesto, California, United States, 95356
- Recruiting
- Kaiser Permanente-Modesto
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Oakland, California, United States, 94611
- Recruiting
- Kaiser Permanente-Oakland
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Oakland, California, United States, 94611
- Recruiting
- Kaiser Permanente Oakland-Broadway
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Orange, California, United States, 92868
- Recruiting
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Principal Investigator:
- Erin H. Healy
-
Contact:
- Site Public Contact
- Phone Number: 877-827-8839
- Email: ucstudy@uci.edu
-
Palo Alto, California, United States, 94304
- Recruiting
- Stanford Cancer Institute Palo Alto
-
Principal Investigator:
- Irene L. Wapnir
-
Contact:
- Site Public Contact
- Phone Number: 650-498-7061
- Email: ccto-office@stanford.edu
-
Pomona, California, United States, 91767
- Recruiting
- Pomona Valley Hospital Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 909-865-9555
-
Principal Investigator:
- Sri G. Gorty
-
Rancho Cordova, California, United States, 95670
- Recruiting
- Kaiser Permanente-Rancho Cordova Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Redwood City, California, United States, 94063
- Recruiting
- Kaiser Permanente- Marshall Medical Offices
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
-
Principal Investigator:
- Samantha A. Seaward
-
Richmond, California, United States, 94801
- Recruiting
- Kaiser Permanente-Richmond
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Rohnert Park, California, United States, 94928
- Recruiting
- Rohnert Park Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Roseville, California, United States, 95661
- Recruiting
- Kaiser Permanente-Roseville
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Roseville, California, United States, 95661
- Recruiting
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Principal Investigator:
- Christopher U. Jones
-
Contact:
- Site Public Contact
- Email: NCIclinicaltrials@sutterhealth.org
-
Roseville, California, United States, 95661
- Recruiting
- Sutter Roseville Medical Center
-
Principal Investigator:
- Christopher U. Jones
-
Contact:
- Site Public Contact
- Email: NCIclinicaltrials@sutterhealth.org
-
Roseville, California, United States, 95678
- Recruiting
- The Permanente Medical Group-Roseville Radiation Oncology
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Sacramento, California, United States, 95817
- Recruiting
- University of California Davis Comprehensive Cancer Center
-
Principal Investigator:
- Xiao Zhao
-
Contact:
- Site Public Contact
- Phone Number: 916-734-3089
-
Sacramento, California, United States, 95814
- Recruiting
- Kaiser Permanente Downtown Commons
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Sacramento, California, United States, 95816
- Recruiting
- Sutter Medical Center Sacramento
-
Principal Investigator:
- Christopher U. Jones
-
Contact:
- Site Public Contact
- Email: NCIclinicaltrials@sutterhealth.org
-
Sacramento, California, United States, 95823
- Recruiting
- Kaiser Permanente-South Sacramento
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Sacramento, California, United States, 95823
- Recruiting
- South Sacramento Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
San Francisco, California, United States, 94115
- Recruiting
- California Pacific Medical Center-Pacific Campus
-
Principal Investigator:
- Christopher U. Jones
-
Contact:
- Site Public Contact
- Email: NCIclinicaltrials@sutterhealth.org
-
San Francisco, California, United States, 94115
- Recruiting
- Kaiser Permanente-San Francisco
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
San Jose, California, United States, 95119
- Recruiting
- Kaiser Permanente-Santa Teresa-San Jose
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
San Jose, California, United States, 95124
- Recruiting
- Stanford Cancer Center South Bay
-
Principal Investigator:
- Irene L. Wapnir
-
Contact:
- Site Public Contact
- Phone Number: 650-498-7061
- Email: ccto-office@stanford.edu
-
San Leandro, California, United States, 94577
- Recruiting
- Kaiser Permanente San Leandro
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
San Luis Obispo, California, United States, 93401
- Recruiting
- Pacific Central Coast Health Center-San Luis Obispo
-
Principal Investigator:
- Shahzad Siddique
-
Contact:
- Site Public Contact
- Phone Number: 805-219-4673
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
San Rafael, California, United States, 94903
- Recruiting
- Kaiser San Rafael-Gallinas
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Santa Barbara, California, United States, 93105
- Recruiting
- Ridley-Tree Cancer Center
-
Contact:
- Site Public Contact
- Email: research@ridleytreecc.org
-
Principal Investigator:
- Shane E. Cotter
-
Santa Clara, California, United States, 95051
- Recruiting
- Kaiser Permanente Medical Center - Santa Clara
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Santa Maria, California, United States, 93444
- Recruiting
- Mission Hope Medical Oncology - Santa Maria
-
Principal Investigator:
- Shahzad Siddique
-
Contact:
- Site Public Contact
- Phone Number: 805-219-4673
- Email: ResearchInstituteInquiries@CommonSpirit.org
-
Santa Rosa, California, United States, 95403
- Recruiting
- Kaiser Permanente-Santa Rosa
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
South Pasadena, California, United States, 91030
- Recruiting
- City of Hope South Pasadena
-
Principal Investigator:
- Jose G. Bazan
-
Contact:
- Site Public Contact
- Phone Number: 800-826-4673
- Email: becomingapatient@coh.org
-
South San Francisco, California, United States, 94080
- Recruiting
- Kaiser Permanente-South San Francisco
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
South San Francisco, California, United States, 94080
- Recruiting
- Kaiser Permanente Cancer Treatment Center
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Stockton, California, United States, 95210
- Recruiting
- Kaiser Permanente-Stockton
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Torrance, California, United States, 90505
- Recruiting
- Torrance Memorial Physician Network - Cancer Care
-
Contact:
- Site Public Contact
- Phone Number: 310-750-3300
- Email: courtney.steeneken@tmphysicians.com
-
Principal Investigator:
- Armando E. Giuliano
-
Torrance, California, United States, 90503
- Recruiting
- City of Hope South Bay
-
Principal Investigator:
- Jose G. Bazan
-
Contact:
- Site Public Contact
- Phone Number: 877-467-3411
-
Upland, California, United States, 91786
- Recruiting
- City of Hope Upland
-
Principal Investigator:
- Jose G. Bazan
-
Contact:
- Site Public Contact
- Phone Number: 800-826-4673
- Email: becomingapatient@coh.org
-
Vacaville, California, United States, 95688
- Recruiting
- Kaiser Permanente Medical Center-Vacaville
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Vallejo, California, United States, 94589
- Recruiting
- Kaiser Permanente-Vallejo
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
Walnut Creek, California, United States, 94596
- Recruiting
- Kaiser Permanente-Walnut Creek
-
Contact:
- Site Public Contact
- Phone Number: 877-642-4691
- Email: Kpoct@kp.org
-
Principal Investigator:
- Samantha A. Seaward
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Recruiting
- UCHealth University of Colorado Hospital
-
Principal Investigator:
- Rachel A. Rabinovitch
-
Contact:
- Site Public Contact
- Phone Number: 720-848-0650
-
Colorado Springs, Colorado, United States, 80909
- Recruiting
- UCHealth Memorial Hospital Central
-
Principal Investigator:
- Rachel A. Rabinovitch
-
Contact:
- Site Public Contact
- Phone Number: 719-365-2406
-
Colorado Springs, Colorado, United States, 80920
- Recruiting
- Memorial Hospital North
-
Principal Investigator:
- Rachel A. Rabinovitch
-
Contact:
- Site Public Contact
- Phone Number: 719-364-6700
-
Colorado Springs, Colorado, United States, 80907
- Recruiting
- Rocky Mountain Cancer Centers-Penrose
-
Principal Investigator:
- Shahzad Siddique
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Colorado Springs, Colorado, United States, 80923
- Recruiting
- Saint Francis Cancer Center
-
Principal Investigator:
- Shahzad Siddique
-
Contact:
- Site Public Contact
- Phone Number: 719-776-6550
- Email: ResearchTracking@Centura.Org
-
Fort Collins, Colorado, United States, 80524
- Recruiting
- Poudre Valley Hospital
-
Principal Investigator:
- Rachel A. Rabinovitch
-
Contact:
- Site Public Contact
- Phone Number: 970-297-6150
-
Fort Collins, Colorado, United States, 80528
- Recruiting
- Cancer Care and Hematology-Fort Collins
-
Principal Investigator:
- Rachel A. Rabinovitch
-
Contact:
- Site Public Contact
- Phone Number: 412-339-5294
- Email: Roster@nrgoncology.org
-
Greeley, Colorado, United States, 80631
- Recruiting
- UCHealth Greeley Hospital
-
Principal Investigator:
- Rachel A. Rabinovitch
-
Contact:
- Site Public Contact
- Phone Number: 412-339-5294
- Email: Roster@nrgoncology.org
-
Highlands Ranch, Colorado, United States, 80129
- Recruiting
- UCHealth Highlands Ranch Hospital
-
Principal Investigator:
- Rachel A. Rabinovitch
-
Contact:
- Site Public Contact
- Phone Number: 720-848-0650
-
Loveland, Colorado, United States, 80538
- Recruiting
- Medical Center of the Rockies
-
Principal Investigator:
- Rachel A. Rabinovitch
-
Contact:
- Site Public Contact
- Phone Number: 970-203-7083
-
-
Florida
-
Atlantis, Florida, United States, 33462
- Recruiting
- John Fitzgerald Kennedy Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 561-964-2662
-
Principal Investigator:
- Georges F. Hatoum
-
Clearwater, Florida, United States, 33756
- Recruiting
- Morton Plant Hospital
-
Contact:
- Site Public Contact
- Phone Number: 855-314-8646
-
Principal Investigator:
- Roberto Diaz
-
Fort Myers, Florida, United States, 33905
- Recruiting
- Regional Cancer Center-Lee Memorial Health System
-
Contact:
- Site Public Contact
- Phone Number: 412-339-5294
- Email: Roster@nrgoncology.org
-
Principal Investigator:
- Kristina Mirabeau-Beale
-
Fort Myers, Florida, United States, 33901
- Recruiting
- Lee Memorial Health System
-
Contact:
- Site Public Contact
- Phone Number: 877-680-0008
-
Principal Investigator:
- Kristina Mirabeau-Beale
-
Orlando, Florida, United States, 32806
- Recruiting
- Orlando Health Cancer Institute
-
Principal Investigator:
- Patrick Kelly
-
Contact:
- Site Public Contact
- Phone Number: 321-841-7246
- Email: CancerClinicalTrials@orlandohealth.com
-
Plantation, Florida, United States, 33324
- Recruiting
- GenesisCare USA - Plantation
-
Contact:
- Site Public Contact
- Phone Number: 941-833-5700
- Email: Rudi.Ross@usa.genesiscare.com
-
Principal Investigator:
- Frank A. Vicini
-
-
Georgia
-
Valdosta, Georgia, United States, 31602
- Recruiting
- South Georgia Medical Center/Pearlman Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 229-259-4628
- Email: maryann.heddon@sgmc.org
-
Principal Investigator:
- Samuel N. Ofori
-
-
Hawaii
-
'Aiea, Hawaii, United States, 96701
- Recruiting
- The Cancer Center of Hawaii-Pali Momi
-
Contact:
- Site Public Contact
- Phone Number: 808-678-9000
-
Principal Investigator:
- Samuel Birer
-
Honolulu, Hawaii, United States, 96813
- Recruiting
- University of Hawaii Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 808-586-2979
-
Principal Investigator:
- Samuel Birer
-
-
Idaho
-
Boise, Idaho, United States, 83712
- Recruiting
- Saint Luke's Cancer Institute - Boise
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
Principal Investigator:
- Nitya Alluri
-
Fruitland, Idaho, United States, 83619
- Recruiting
- Saint Luke's Cancer Institute - Fruitland
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
Principal Investigator:
- Nitya Alluri
-
Meridian, Idaho, United States, 83642
- Recruiting
- Saint Luke's Cancer Institute - Meridian
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
Principal Investigator:
- Nitya Alluri
-
Nampa, Idaho, United States, 83686
- Recruiting
- Saint Luke's Cancer Institute - Nampa
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
Principal Investigator:
- Nitya Alluri
-
Twin Falls, Idaho, United States, 83301
- Recruiting
- Saint Luke's Cancer Institute - Twin Falls
-
Contact:
- Site Public Contact
- Phone Number: 208-381-2774
- Email: eslinget@slhs.org
-
Principal Investigator:
- Nitya Alluri
-
-
Illinois
-
Aurora, Illinois, United States, 60504
- Recruiting
- Rush - Copley Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 630-978-6212
- Email: Cancer.Research@rushcopley.com
-
Principal Investigator:
- Kalika P. Sarma
-
Centralia, Illinois, United States, 62801
- Recruiting
- Centralia Oncology Clinic
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 217-876-4762
- Email: morganthaler.jodi@mhsil.com
-
Centralia, Illinois, United States, 62801
- Recruiting
- Saint Mary's Hospital
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 412-339-5294
- Email: Roster@nrgoncology.org
-
Chicago, Illinois, United States, 60611
- Recruiting
- Northwestern University
-
Contact:
- Site Public Contact
- Phone Number: 312-695-1301
- Email: cancer@northwestern.edu
-
Principal Investigator:
- Eric D. Donnelly
-
Chicago, Illinois, United States, 60612
- Recruiting
- John H Stroger Jr Hospital of Cook County
-
Contact:
- Site Public Contact
- Phone Number: 312-864-5204
-
Principal Investigator:
- Thomas E. Lad
-
Danville, Illinois, United States, 61832
- Recruiting
- Carle at The Riverfront
-
Contact:
- Site Public Contact
- Phone Number: 800-446-5532
- Email: Research@carle.com
-
Principal Investigator:
- Kalika P. Sarma
-
DeKalb, Illinois, United States, 60115
- Recruiting
- Northwestern Medicine Cancer Center Kishwaukee
-
Contact:
- Site Public Contact
- Phone Number: 630-352-5360
- Email: Donald.Smith3@nm.org
-
Principal Investigator:
- Eric D. Donnelly
-
Decatur, Illinois, United States, 62526
- Recruiting
- Cancer Care Specialists of Illinois - Decatur
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 217-876-4762
- Email: morganthaler.jodi@mhsil.com
-
Decatur, Illinois, United States, 62526
- Recruiting
- Decatur Memorial Hospital
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 217-876-4762
- Email: morganthaler.jodi@mhsil.com
-
Effingham, Illinois, United States, 62401
- Recruiting
- Carle Physician Group-Effingham
-
Contact:
- Site Public Contact
- Phone Number: 800-446-5532
- Email: Research@carle.com
-
Principal Investigator:
- Kalika P. Sarma
-
Effingham, Illinois, United States, 62401
- Recruiting
- Crossroads Cancer Center
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 217-876-4762
- Email: morganthaler.jodi@mhsil.com
-
Geneva, Illinois, United States, 60134
- Recruiting
- Northwestern Medicine Cancer Center Delnor
-
Contact:
- Site Public Contact
- Phone Number: 630-352-5360
- Email: Donald.Smith3@nm.org
-
Principal Investigator:
- Eric D. Donnelly
-
Lake Forest, Illinois, United States, 60045
- Recruiting
- Northwestern Medicine Lake Forest Hospital
-
Contact:
- Site Public Contact
- Email: cancertrials@northwestern.edu
-
Principal Investigator:
- Eric D. Donnelly
-
Mattoon, Illinois, United States, 61938
- Recruiting
- Carle Physician Group-Mattoon/Charleston
-
Contact:
- Site Public Contact
- Phone Number: 800-446-5532
- Email: Research@carle.com
-
Principal Investigator:
- Kalika P. Sarma
-
Maywood, Illinois, United States, 60153
- Recruiting
- Loyola University Medical Center
-
Principal Investigator:
- William Small
-
Contact:
- Site Public Contact
- Phone Number: 708-226-4357
-
O'Fallon, Illinois, United States, 62269
- Recruiting
- Cancer Care Center of O'Fallon
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 217-876-4762
- Email: morganthaler.jodi@mhsil.com
-
O'Fallon, Illinois, United States, 62269
- Recruiting
- HSHS Saint Elizabeth's Hospital
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 217-876-4762
- Email: morganthaler.jodi@mhsil.com
-
Springfield, Illinois, United States, 62702
- Recruiting
- Southern Illinois University School of Medicine
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 217-545-7929
-
Springfield, Illinois, United States, 62702
- Recruiting
- Springfield Clinic
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 800-444-7541
-
Springfield, Illinois, United States, 62781
- Recruiting
- Memorial Medical Center
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 217-528-7541
- Email: pallante.beth@mhsil.com
-
Urbana, Illinois, United States, 61801
- Recruiting
- Carle Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 800-446-5532
- Email: Research@carle.com
-
Principal Investigator:
- Kalika P. Sarma
-
Warrenville, Illinois, United States, 60555
- Recruiting
- Northwestern Medicine Cancer Center Warrenville
-
Contact:
- Site Public Contact
- Phone Number: 630-352-5360
- Email: Donald.Smith3@nm.org
-
Principal Investigator:
- Eric D. Donnelly
-
Zion, Illinois, United States, 60099
- Recruiting
- Midwestern Regional Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 844-793-0745
-
Principal Investigator:
- Karan K. Shah
-
-
Indiana
-
Crown Point, Indiana, United States, 46307
- Recruiting
- Northwest Cancer Center - Main Campus
-
Contact:
- Site Public Contact
- Phone Number: 219-310-2550
-
Principal Investigator:
- Kalika P. Sarma
-
Dyer, Indiana, United States, 46311
- Recruiting
- Northwest Oncology LLC
-
Contact:
- Site Public Contact
- Phone Number: 219-924-8178
-
Principal Investigator:
- Kalika P. Sarma
-
Goshen, Indiana, United States, 46526
- Recruiting
- Goshen Center for Cancer Care
-
Contact:
- Site Public Contact
- Phone Number: 574-364-2973
- Email: cccois@goshenhealth.com
-
Principal Investigator:
- James A. Wheeler
-
Hobart, Indiana, United States, 46342
- Recruiting
- Northwest Cancer Center - Hobart
-
Contact:
- Site Public Contact
- Phone Number: 219-947-1795
-
Principal Investigator:
- Kalika P. Sarma
-
Hobart, Indiana, United States, 46342
- Recruiting
- Saint Mary Medical Center
-
Principal Investigator:
- Kalika P. Sarma
-
Contact:
- Site Public Contact
- Phone Number: 219-836-6875
- Email: CancerResearch@COMHS.org
-
Munster, Indiana, United States, 46321
- Recruiting
- The Community Hospital
-
Contact:
- Site Public Contact
- Phone Number: 219-836-3349
-
Principal Investigator:
- Kalika P. Sarma
-
Munster, Indiana, United States, 46321
- Recruiting
- Women's Diagnostic Center - Munster
-
Contact:
- Site Public Contact
- Phone Number: 219-934-8869
- Email: mnicholson@comhs.org
-
Principal Investigator:
- Kalika P. Sarma
-
Richmond, Indiana, United States, 47374
- Recruiting
- Reid Health
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
South Bend, Indiana, United States, 46601
- Suspended
- Memorial Hospital of South Bend
-
Valparaiso, Indiana, United States, 46383
- Recruiting
- Northwest Cancer Center - Valparaiso
-
Principal Investigator:
- Kalika P. Sarma
-
Contact:
- Site Public Contact
- Phone Number: 219-836-6875
- Email: CancerResearch@COMHS.org
-
-
Iowa
-
Ankeny, Iowa, United States, 50023
- Recruiting
- Mission Cancer and Blood - Ankeny
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-282-2921
-
Cedar Rapids, Iowa, United States, 52402
- Recruiting
- Physicians' Clinic of Iowa PC
-
Contact:
- Site Public Contact
- Phone Number: 319-297-2900
-
Principal Investigator:
- Bharat Jenigiri
-
Clive, Iowa, United States, 50325
- Recruiting
- Medical Oncology and Hematology Associates-West Des Moines
-
Contact:
- Site Public Contact
- Phone Number: 515-241-3305
-
Principal Investigator:
- Richard L. Deming
-
Clive, Iowa, United States, 50325
- Recruiting
- Mercy Cancer Center-West Lakes
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-358-6613
- Email: cancerresearch@mercydesmoines.org
-
Creston, Iowa, United States, 50801
- Recruiting
- Greater Regional Medical Center
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-358-6613
- Email: cancerresearch@mercydesmoines.org
-
Des Moines, Iowa, United States, 50309
- Recruiting
- Medical Oncology and Hematology Associates-Des Moines
-
Principal Investigator:
- Joshua Lukenbill
-
Contact:
- Site Public Contact
- Phone Number: 515-241-3305
-
Des Moines, Iowa, United States, 50314
- Recruiting
- Mercy Medical Center - Des Moines
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-358-6613
- Email: cancerresearch@mercydesmoines.org
-
Des Moines, Iowa, United States, 50314
- Recruiting
- Mission Cancer and Blood - Laurel
-
Contact:
- Site Public Contact
- Phone Number: 515-241-3305
-
Principal Investigator:
- Richard L. Deming
-
Des Moines, Iowa, United States, 50309
- Recruiting
- Iowa Methodist Medical Center
-
Principal Investigator:
- Joshua Lukenbill
-
Contact:
- Site Public Contact
- Phone Number: 515-241-6727
-
West Des Moines, Iowa, United States, 50266
- Recruiting
- Mercy Medical Center-West Lakes
-
Principal Investigator:
- Richard L. Deming
-
Contact:
- Site Public Contact
- Phone Number: 515-358-6613
- Email: cancerresearch@mercydesmoines.org
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- Recruiting
- University of Kansas Cancer Center
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 913-588-3671
- Email: KUCC_Navigation@kumc.edu
-
Olathe, Kansas, United States, 66061
- Recruiting
- Olathe Health Cancer Center
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 913-355-8000
- Email: Jeni.wakefield@olathehealth.org
-
Overland Park, Kansas, United States, 66211
- Recruiting
- University of Kansas Hospital-Indian Creek Campus
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 913-588-3671
- Email: KUCC_Navigation@kumc.edu
-
Overland Park, Kansas, United States, 66210
- Recruiting
- University of Kansas Cancer Center-Overland Park
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 913-588-3671
- Email: KUCC_Navigation@kumc.edu
-
Salina, Kansas, United States, 67401
- Recruiting
- Salina Regional Health Center
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 785-452-7038
- Email: mleepers@srhc.com
-
Topeka, Kansas, United States, 66606
- Recruiting
- University of Kansas Health System Saint Francis Campus
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 785-295-8000
-
Westwood, Kansas, United States, 66205
- Recruiting
- University of Kansas Hospital-Westwood Cancer Center
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 913-588-3671
- Email: KUCC_Navigation@kumc.edu
-
-
Maryland
-
Baltimore, Maryland, United States, 21204
- Recruiting
- Greater Baltimore Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 443-849-3706
-
Principal Investigator:
- Geoffrey A. Neuner
-
-
Michigan
-
Brownstown, Michigan, United States, 48183
- Recruiting
- Henry Ford Cancer Institute-Downriver
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Eleanor M. Walker
-
Clarkston, Michigan, United States, 48346
- Recruiting
- Michigan Healthcare Professionals Clarkston
-
Principal Investigator:
- Frank A. Vicini
-
Contact:
- Site Public Contact
- Phone Number: 941-833-5700
- Email: rudi.ross@profoundresearch.io
-
Clinton Township, Michigan, United States, 48038
- Recruiting
- Henry Ford Macomb Hospital-Clinton Township
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Eleanor M. Walker
-
Dearborn, Michigan, United States, 48126
- Recruiting
- Henry Ford Medical Center-Fairlane
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Eleanor M. Walker
-
Detroit, Michigan, United States, 48202
- Recruiting
- Henry Ford Hospital
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Eleanor M. Walker
-
Farmington Hills, Michigan, United States, 48334
- Recruiting
- Michigan Healthcare Professionals Farmington
-
Principal Investigator:
- Frank A. Vicini
-
Contact:
- Site Public Contact
- Phone Number: 941-833-5700
- Email: rudi.ross@profoundresearch.io
-
Flint, Michigan, United States, 48503
- Recruiting
- Genesys Hurley Cancer Institute
-
Contact:
- Site Public Contact
- Phone Number: 810-762-8038
- Email: wstrong@ghci.org
-
Principal Investigator:
- Tareq Al Baghdadi
-
Flint, Michigan, United States, 48503
- Recruiting
- Hurley Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 810-762-8038
- Email: wstrong@ghci.org
-
Principal Investigator:
- Tareq Al Baghdadi
-
Jackson, Michigan, United States, 49201
- Recruiting
- Allegiance Health
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Eleanor M. Walker
-
Macomb, Michigan, United States, 48044
- Recruiting
- Michigan Healthcare Professionals Macomb
-
Principal Investigator:
- Frank A. Vicini
-
Contact:
- Site Public Contact
- Email: rudi.ross@profoundresearch.io
-
Madison Heights, Michigan, United States, 48071
- Recruiting
- Michigan Healthcare Professionals Madison Heights
-
Principal Investigator:
- Frank A. Vicini
-
Contact:
- Site Public Contact
- Phone Number: 941-833-5700
- Email: rudi.ross@profoundresearch.io
-
Novi, Michigan, United States, 48377
- Recruiting
- Henry Ford Medical Center-Columbus
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Eleanor M. Walker
-
Pontiac, Michigan, United States, 48341
- Recruiting
- Saint Joseph Mercy Oakland
-
Contact:
- Site Public Contact
- Phone Number: 734-712-7251
- Email: MCRCwebsitecontactform@stjoeshealth.org
-
Principal Investigator:
- Tareq Al Baghdadi
-
Royal Oak, Michigan, United States, 48073
- Recruiting
- William Beaumont Hospital-Royal Oak
-
Principal Investigator:
- Peter Y. Chen
-
Contact:
- Site Public Contact
- Phone Number: 248-551-7695
-
Troy, Michigan, United States, 48085
- Recruiting
- William Beaumont Hospital - Troy
-
Principal Investigator:
- Peter Y. Chen
-
Contact:
- Site Public Contact
- Phone Number: 248-551-7695
-
Troy, Michigan, United States, 48098
- Recruiting
- GenesisCare USA - Troy
-
Principal Investigator:
- Frank A. Vicini
-
Contact:
- Site Public Contact
- Email: rudi.ross@profoundresearch.io
-
West Bloomfield, Michigan, United States, 48322
- Recruiting
- Henry Ford West Bloomfield Hospital
-
Contact:
- Site Public Contact
- Phone Number: 313-916-3721
- Email: CTOResearch@hfhs.org
-
Principal Investigator:
- Eleanor M. Walker
-
-
Minnesota
-
Bemidji, Minnesota, United States, 56601
- Recruiting
- Sanford Joe Lueken Cancer Center
-
Principal Investigator:
- Daniel Almquist
-
Contact:
- Site Public Contact
- Phone Number: 218-333-5000
- Email: OncologyClinicalTrialsFargo@sanfordhealth.org
-
Duluth, Minnesota, United States, 55805
- Recruiting
- Saint Luke's Hospital of Duluth
-
Principal Investigator:
- Steven R. Bonin
-
Contact:
- Site Public Contact
- Phone Number: 218-249-7825
- Email: kdean@slhduluth.com
-
-
Mississippi
-
Columbus, Mississippi, United States, 39705
- Recruiting
- Baptist Memorial Hospital and Cancer Center-Golden Triangle
-
Principal Investigator:
- Michael Tomblyn
-
Contact:
- Site Public Contact
- Phone Number: 901-226-1366
- Email: BCCclintrials@bmhcc.org
-
Grenada, Mississippi, United States, 38901
- Recruiting
- Baptist Cancer Center-Grenada
-
Principal Investigator:
- Michael Tomblyn
-
Contact:
- Site Public Contact
- Phone Number: 901-226-1366
- Email: BCCclintrials@bmhcc.org
-
New Albany, Mississippi, United States, 38652
- Recruiting
- Baptist Memorial Hospital and Cancer Center-Union County
-
Principal Investigator:
- Michael Tomblyn
-
Contact:
- Site Public Contact
- Phone Number: 901-226-1366
- Email: BCCclintrials@bmhcc.org
-
Oxford, Mississippi, United States, 38655
- Recruiting
- Baptist Memorial Hospital and Cancer Center-Oxford
-
Principal Investigator:
- Michael Tomblyn
-
Contact:
- Site Public Contact
- Phone Number: 901-226-1366
- Email: BCCclintrials@bmhcc.org
-
Southhaven, Mississippi, United States, 38671
- Recruiting
- Baptist Memorial Hospital and Cancer Center-Desoto
-
Principal Investigator:
- Michael Tomblyn
-
Contact:
- Site Public Contact
- Phone Number: 901-226-1366
- Email: BCCclintrials@bmhcc.org
-
-
Missouri
-
Cape Girardeau, Missouri, United States, 63703
- Recruiting
- Saint Francis Medical Center
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 573-334-2230
- Email: sfmc@sfmc.net
-
Farmington, Missouri, United States, 63640
- Recruiting
- Parkland Health Center - Farmington
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 314-996-5569
-
Kansas City, Missouri, United States, 64154
- Recruiting
- University of Kansas Cancer Center - North
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 913-588-3671
- Email: KUCC_Navigation@kumc.edu
-
Lee's Summit, Missouri, United States, 64064
- Recruiting
- University of Kansas Cancer Center - Lee's Summit
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 913-588-3671
- Email: KUCC_Navigation@kumc.edu
-
North Kansas City, Missouri, United States, 64116
- Recruiting
- University of Kansas Cancer Center at North Kansas City Hospital
-
Principal Investigator:
- Shane R. Stecklein
-
Contact:
- Site Public Contact
- Phone Number: 913-588-3671
- Email: KUCC_Navigation@kumc.edu
-
Saint Louis, Missouri, United States, 63141
- Recruiting
- Mercy Hospital Saint Louis
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 314-251-7066
-
Saint Louis, Missouri, United States, 63131
- Recruiting
- Missouri Baptist Medical Center
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 314-996-5569
-
Saint Louis, Missouri, United States, 63128
- Recruiting
- Mercy Hospital South
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 314-525-6042
- Email: Danielle.Werle@mercy.net
-
Sainte Genevieve, Missouri, United States, 63670
- Recruiting
- Sainte Genevieve County Memorial Hospital
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 314-996-5569
-
Springfield, Missouri, United States, 65804
- Recruiting
- Mercy Hospital Springfield
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 417-269-4520
-
Sullivan, Missouri, United States, 63080
- Recruiting
- Missouri Baptist Sullivan Hospital
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 314-996-5569
-
Sunset Hills, Missouri, United States, 63127
- Recruiting
- BJC Outpatient Center at Sunset Hills
-
Principal Investigator:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Phone Number: 314-996-5569
-
-
Montana
-
Billings, Montana, United States, 59101
- Recruiting
- Billings Clinic Cancer Center
-
Principal Investigator:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Phone Number: 800-996-2663
- Email: research@billingsclinic.org
-
-
Nebraska
-
Bellevue, Nebraska, United States, 68123
- Recruiting
- Nebraska Medicine-Bellevue
-
Contact:
- Site Public Contact
- Phone Number: 402-559-6941
- Email: unmcrsa@unmc.edu
-
Principal Investigator:
- Andrew O. Wahl
-
Lincoln, Nebraska, United States, 68516
- Recruiting
- Cancer Partners of Nebraska - Pine Lake
-
Principal Investigator:
- Mark J. Stavas
-
Contact:
- Site Public Contact
- Phone Number: 402-327-7363
- Email: research@cancerpartners.com
-
Lincoln, Nebraska, United States, 68516
- Recruiting
- Southeast Nebraska Cancer Center - 68th Street Place
-
Principal Investigator:
- Mark J. Stavas
-
Contact:
- Site Public Contact
- Phone Number: 402-327-7363
- Email: research@cancerpartners.com
-
Omaha, Nebraska, United States, 68118
- Recruiting
- Nebraska Medicine-Village Pointe
-
Contact:
- Site Public Contact
- Phone Number: 402-559-5600
-
Principal Investigator:
- Andrew O. Wahl
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Recruiting
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 800-639-6918
- Email: cancer.research.nurse@dartmouth.edu
-
Principal Investigator:
- Shauna McVorran
-
-
New Jersey
-
Basking Ridge, New Jersey, United States, 07920
- Recruiting
- Memorial Sloan Kettering Basking Ridge
-
Principal Investigator:
- Diana Roth O'Brien
-
Contact:
- Site Public Contact
- Phone Number: 212-639-7592
-
Middletown, New Jersey, United States, 07748
- Recruiting
- Memorial Sloan Kettering Monmouth
-
Principal Investigator:
- Diana Roth O'Brien
-
Contact:
- Site Public Contact
- Phone Number: 212-639-7592
-
Montvale, New Jersey, United States, 07645
- Recruiting
- Memorial Sloan Kettering Bergen
-
Principal Investigator:
- Diana Roth O'Brien
-
Contact:
- Site Public Contact
- Phone Number: 212-639-7592
-
-
New York
-
Bronx, New York, United States, 10461
- Recruiting
- Montefiore Medical Center-Einstein Campus
-
Principal Investigator:
- Jana L. Fox
-
Contact:
- Site Public Contact
- Phone Number: 718-379-6866
- Email: eskwak@montefiore.org
-
Bronx, New York, United States, 10467
- Recruiting
- Montefiore Medical Center - Moses Campus
-
Principal Investigator:
- Jana L. Fox
-
Contact:
- Site Public Contact
- Phone Number: 718-379-6866
- Email: eskwak@montefiore.org
-
Bronx, New York, United States, 10461
- Recruiting
- Montefiore Medical Center-Weiler Hospital
-
Principal Investigator:
- Jana L. Fox
-
Contact:
- Site Public Contact
- Phone Number: 718-379-6866
- Email: eskwak@montefiore.org
-
Canandaigua, New York, United States, 14424
- Recruiting
- Sands Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 585-396-6161
-
Principal Investigator:
- Yuhchyau Chen
-
Commack, New York, United States, 11725
- Recruiting
- Memorial Sloan Kettering Commack
-
Principal Investigator:
- Diana Roth O'Brien
-
Contact:
- Site Public Contact
- Phone Number: 212-639-7592
-
Dansville, New York, United States, 14437
- Recruiting
- Noyes Memorial Hospital/Myers Cancer Center
-
Principal Investigator:
- Yuhchyau Chen
-
Contact:
- Site Public Contact
- Email: WCICTOresearch@urmc.rochester.edu
-
Harrison, New York, United States, 10604
- Recruiting
- Memorial Sloan Kettering Westchester
-
Principal Investigator:
- Diana Roth O'Brien
-
Contact:
- Site Public Contact
- Phone Number: 212-639-7592
-
New York, New York, United States, 10032
- Recruiting
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
-
Principal Investigator:
- Eileen P. Connolly
-
Contact:
- Site Public Contact
- Phone Number: 212-342-5162
- Email: cancerclinicaltrials@cumc.columbia.edu
-
New York, New York, United States, 10065
- Recruiting
- Memorial Sloan Kettering Cancer Center
-
Principal Investigator:
- Diana Roth O'Brien
-
Contact:
- Site Public Contact
- Phone Number: 212-639-7592
-
Rochester, New York, United States, 14642
- Recruiting
- University of Rochester
-
Principal Investigator:
- Yuhchyau Chen
-
Contact:
- Site Public Contact
- Phone Number: 585-275-5830
-
Rochester, New York, United States, 14620
- Recruiting
- Highland Hospital
-
Principal Investigator:
- Yuhchyau Chen
-
Contact:
- Site Public Contact
- Phone Number: 585-341-8113
-
Rochester, New York, United States, 14606
- Recruiting
- Wilmot Cancer Institute Radiation Oncology at Greece
-
Principal Investigator:
- Yuhchyau Chen
-
Contact:
- Site Public Contact
- Phone Number: 585-758-7877
-
Rochester, New York, United States, 14623
- Recruiting
- Pluta Cancer Center
-
Principal Investigator:
- Yuhchyau Chen
-
Contact:
- Site Public Contact
- Phone Number: 412-339-5294
- Email: Roster@nrgoncology.org
-
Stony Brook, New York, United States, 11794
- Recruiting
- Stony Brook University Medical Center
-
Principal Investigator:
- Alexander M. Stessin
-
Contact:
- Site Public Contact
- Phone Number: 800-862-2215
-
Uniondale, New York, United States, 11553
- Recruiting
- Memorial Sloan Kettering Nassau
-
Principal Investigator:
- Diana Roth O'Brien
-
Contact:
- Site Public Contact
- Phone Number: 212-639-7592
-
Webster, New York, United States, 14580
- Recruiting
- Wilmot Cancer Institute at Webster
-
Principal Investigator:
- Yuhchyau Chen
-
Contact:
- Site Public Contact
- Email: WCICTOresearch@urmc.rochester.edu
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Recruiting
- Wake Forest University Health Sciences
-
Contact:
- Site Public Contact
- Phone Number: 336-713-6771
-
Principal Investigator:
- Marissa M. Howard-McNatt
-
-
North Dakota
-
Bismarck, North Dakota, United States, 58501
- Recruiting
- Sanford Bismarck Medical Center
-
Principal Investigator:
- Daniel Almquist
-
Contact:
- Site Public Contact
- Phone Number: 701-323-5760
- Email: OncologyClinicalTrialsFargo@sanfordhealth.org
-
Fargo, North Dakota, United States, 58122
- Recruiting
- Sanford Broadway Medical Center
-
Principal Investigator:
- Daniel Almquist
-
Contact:
- Site Public Contact
- Phone Number: 701-323-5760
- Email: OncologyClinicalTrialsFargo@sanfordhealth.org
-
Fargo, North Dakota, United States, 58122
- Recruiting
- Sanford Roger Maris Cancer Center
-
Principal Investigator:
- Daniel Almquist
-
Contact:
- Site Public Contact
- Phone Number: 701-234-6161
- Email: OncologyClinicalTrialsFargo@sanfordhealth.org
-
-
Ohio
-
Beavercreek, Ohio, United States, 45431
- Recruiting
- Indu and Raj Soin Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Canton, Ohio, United States, 44708
- Recruiting
- Cleveland Clinic Mercy Hospital
-
Principal Investigator:
- Edward J. Walsh
-
Contact:
- Site Public Contact
- Phone Number: 888-293-4673
-
Centerville, Ohio, United States, 45459
- Recruiting
- Dayton Physicians LLC-Miami Valley South
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Centerville, Ohio, United States, 45459
- Recruiting
- Miami Valley Hospital South
-
Principal Investigator:
- Jhansi L. Koduri
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Columbus, Ohio, United States, 43210
- Recruiting
- Ohio State University Comprehensive Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 800-293-5066
- Email: Jamesline@osumc.edu
-
Principal Investigator:
- Sachin R. Jhawar
-
Dayton, Ohio, United States, 45409
- Recruiting
- Miami Valley Hospital
-
Principal Investigator:
- Jhansi L. Koduri
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Dayton, Ohio, United States, 45415
- Recruiting
- Dayton Physician LLC-Miami Valley Hospital North
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Dayton, Ohio, United States, 45415
- Recruiting
- Miami Valley Hospital North
-
Principal Investigator:
- Jhansi L. Koduri
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Dayton, Ohio, United States, 45409
- Recruiting
- Dayton Blood and Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 937-276-8320
-
Principal Investigator:
- Jhansi L. Koduri
-
Franklin, Ohio, United States, 45005-1066
- Recruiting
- Atrium Medical Center-Middletown Regional Hospital
-
Principal Investigator:
- Jhansi L. Koduri
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Franklin, Ohio, United States, 45005
- Recruiting
- Dayton Physicians LLC-Atrium
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Greenville, Ohio, United States, 45331
- Recruiting
- Miami Valley Cancer Care and Infusion
-
Principal Investigator:
- Jhansi L. Koduri
-
Contact:
- Site Public Contact
- Phone Number: 937-569-7515
-
Kettering, Ohio, United States, 45429
- Recruiting
- Kettering Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
Troy, Ohio, United States, 45373
- Recruiting
- Upper Valley Medical Center
-
Principal Investigator:
- Jhansi L. Koduri
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Troy, Ohio, United States, 45373
- Recruiting
- Dayton Physicians LLC - Troy
-
Contact:
- Site Public Contact
- Phone Number: 937-528-2900
- Email: clinical.trials@daytonncorp.org
-
Principal Investigator:
- Howard M. Gross
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- Recruiting
- University of Oklahoma Health Sciences Center
-
Principal Investigator:
- Andrea Johnston
-
Contact:
- Site Public Contact
- Phone Number: 405-271-8777
- Email: ou-clinical-trials@ouhsc.edu
-
Oklahoma City, Oklahoma, United States, 73120
- Recruiting
- Mercy Hospital Oklahoma City
-
Principal Investigator:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Phone Number: 405-752-3402
-
-
Oregon
-
Bend, Oregon, United States, 97701
- Recruiting
- Saint Charles Health System
-
Contact:
- Site Public Contact
- Phone Number: 541-706-2909
- Email: nosall@stcharleshealthcare.org
-
Principal Investigator:
- Nitya Alluri
-
Clackamas, Oregon, United States, 97015
- Recruiting
- Providence Cancer Institute Clackamas Clinic
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Principal Investigator:
- Nitya Alluri
-
Clackamas, Oregon, United States, 97015
- Recruiting
- Clackamas Radiation Oncology Center
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Principal Investigator:
- Nitya Alluri
-
Gresham, Oregon, United States, 97030
- Recruiting
- Legacy Mount Hood Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 503-413-2150
-
Principal Investigator:
- Andrew Y. Kee
-
Newberg, Oregon, United States, 97132
- Recruiting
- Providence Newberg Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Principal Investigator:
- Nitya Alluri
-
Oregon City, Oregon, United States, 97045
- Recruiting
- Providence Willamette Falls Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Principal Investigator:
- Nitya Alluri
-
Portland, Oregon, United States, 97213
- Recruiting
- Providence Portland Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Principal Investigator:
- Nitya Alluri
-
Portland, Oregon, United States, 97225
- Recruiting
- Providence Saint Vincent Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 503-215-2614
- Email: CanRsrchStudies@providence.org
-
Principal Investigator:
- Nitya Alluri
-
Portland, Oregon, United States, 97210
- Recruiting
- Legacy Good Samaritan Hospital and Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 800-220-4937
- Email: cancer@lhs.org
-
Principal Investigator:
- Andrew Y. Kee
-
Tualatin, Oregon, United States, 97062
- Recruiting
- Legacy Meridian Park Hospital
-
Contact:
- Site Public Contact
- Phone Number: 503-413-1742
-
Principal Investigator:
- Andrew Y. Kee
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Recruiting
- UPMC-Magee Womens Hospital
-
Principal Investigator:
- Emilia J. Diego
-
Contact:
- Site Public Contact
- Phone Number: 412-647-2811
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02905
- Recruiting
- Women and Infants Hospital
-
Principal Investigator:
- William M. Sikov
-
Contact:
- Site Public Contact
- Phone Number: 401-274-1122
-
Warwick, Rhode Island, United States, 02886
- Recruiting
- Kent Hospital
-
Contact:
- Site Public Contact
- Phone Number: 401-737-7010
-
Principal Investigator:
- Bachir J. Sakr
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Recruiting
- Medical University of South Carolina
-
Contact:
- Site Public Contact
- Phone Number: 843-792-9321
- Email: hcc-clinical-trials@musc.edu
-
Principal Investigator:
- Harriet B. Eldredge-Hindy
-
West Columbia, South Carolina, United States, 29169
- Recruiting
- Lexington Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 803-791-2105
- Email: LMCIRB@lexhealth.org
-
Principal Investigator:
- Steven A. Madden
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57104
- Recruiting
- Sanford Cancer Center Oncology Clinic
-
Principal Investigator:
- Daniel Almquist
-
Contact:
- Site Public Contact
- Phone Number: 605-312-3320
- Email: OncologyClinicTrialsSF@sanfordhealth.org
-
Sioux Falls, South Dakota, United States, 57117-5134
- Recruiting
- Sanford USD Medical Center - Sioux Falls
-
Principal Investigator:
- Daniel Almquist
-
Contact:
- Site Public Contact
- Phone Number: 605-312-3320
- Email: OncologyClinicalTrialsSF@SanfordHealth.org
-
-
Tennessee
-
Collierville, Tennessee, United States, 38017
- Recruiting
- Baptist Memorial Hospital and Cancer Center-Collierville
-
Principal Investigator:
- Michael Tomblyn
-
Contact:
- Site Public Contact
- Phone Number: 901-226-1366
- Email: BCCclintrials@bmhcc.org
-
Memphis, Tennessee, United States, 38120
- Recruiting
- Baptist Memorial Hospital and Cancer Center-Memphis
-
Principal Investigator:
- Michael Tomblyn
-
Contact:
- Site Public Contact
- Phone Number: 901-226-1366
- Email: BCCclintrials@bmhcc.org
-
-
Texas
-
Conroe, Texas, United States, 77384
- Recruiting
- MD Anderson in The Woodlands
-
Contact:
- Site Public Contact
- Phone Number: 866-632-6789
- Email: askmdanderson@mdanderson.org
-
Principal Investigator:
- Melissa P. Mitchell
-
Houston, Texas, United States, 77030
- Recruiting
- M D Anderson Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 877-632-6789
- Email: askmdanderson@mdanderson.org
-
Principal Investigator:
- Melissa P. Mitchell
-
Houston, Texas, United States, 77079
- Recruiting
- MD Anderson West Houston
-
Contact:
- Site Public Contact
- Phone Number: 877-632-6789
- Email: askmdanderson@mdanderson.org
-
Principal Investigator:
- Melissa P. Mitchell
-
League City, Texas, United States, 77573
- Recruiting
- MD Anderson League City
-
Contact:
- Site Public Contact
- Phone Number: 877-632-6789
- Email: askmdanderson@mdanderson.org
-
Principal Investigator:
- Melissa P. Mitchell
-
Sugar Land, Texas, United States, 77478
- Recruiting
- MD Anderson in Sugar Land
-
Contact:
- Site Public Contact
- Phone Number: 877-632-6789
- Email: askmdanderson@mdanderson.org
-
Principal Investigator:
- Melissa P. Mitchell
-
-
Utah
-
Farmington, Utah, United States, 84025
- Recruiting
- Farmington Health Center
-
Principal Investigator:
- Matthew M. Poppe
-
Contact:
- Site Public Contact
- Phone Number: 888-424-2100
- Email: cancerinfo@hci.utah.edu
-
Salt Lake City, Utah, United States, 84106
- Recruiting
- University of Utah Sugarhouse Health Center
-
Principal Investigator:
- Matthew M. Poppe
-
Contact:
- Site Public Contact
- Phone Number: 888-424-2100
- Email: cancerinfo@hci.utah.edu
-
Salt Lake City, Utah, United States, 84112
- Recruiting
- Huntsman Cancer Institute/University of Utah
-
Principal Investigator:
- Matthew M. Poppe
-
Contact:
- Site Public Contact
- Phone Number: 888-424-2100
- Email: cancerinfo@hci.utah.edu
-
-
Vermont
-
Burlington, Vermont, United States, 05401
- Recruiting
- University of Vermont Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 802-656-4101
- Email: rpo@uvm.edu
-
Principal Investigator:
- Puyao Li
-
Burlington, Vermont, United States, 05405
- Recruiting
- University of Vermont and State Agricultural College
-
Contact:
- Site Public Contact
- Phone Number: 802-656-8990
- Email: rpo@uvm.edu
-
Principal Investigator:
- Puyao Li
-
Saint Johnsbury, Vermont, United States, 05819
- Recruiting
- Norris Cotton Cancer Center-North
-
Contact:
- Site Public Contact
- Phone Number: 800-639-6918
- Email: cancer.research.nurse@hitchcock.org
-
Principal Investigator:
- Shauna McVorran
-
-
Virginia
-
Mechanicsville, Virginia, United States, 23116
- Recruiting
- Bon Secours Memorial Regional Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 804-893-8978
- Email: anne_carmellat@bshsi.org
-
Principal Investigator:
- William J. Irvin
-
Midlothian, Virginia, United States, 23114
- Recruiting
- Bon Secours Saint Francis Medical Center
-
Contact:
- Site Public Contact
- Phone Number: 804-893-8978
- Email: anne_carmellat@bshsi.org
-
Principal Investigator:
- William J. Irvin
-
Richmond, Virginia, United States, 23226
- Recruiting
- Bon Secours Saint Mary's Hospital
-
Contact:
- Site Public Contact
- Phone Number: 804-893-8978
- Email: anne_carmellat@bshsi.org
-
Principal Investigator:
- William J. Irvin
-
Richmond, Virginia, United States, 23230
- Recruiting
- Bon Secours Cancer Institute at Reynolds Crossing
-
Contact:
- Site Public Contact
- Phone Number: 804-893-8978
- Email: Anne_caramella@bshsi.org
-
Principal Investigator:
- William J. Irvin
-
-
Washington
-
Issaquah, Washington, United States, 98029
- Recruiting
- Swedish Cancer Institute-Issaquah
-
Contact:
- Site Public Contact
- Phone Number: 206-215-3086
- Email: PCRC-NCORP@Swedish.org
-
Principal Investigator:
- Nitya Alluri
-
Seattle, Washington, United States, 98122
- Recruiting
- Swedish Medical Center-First Hill
-
Contact:
- Site Public Contact
- Phone Number: 206-215-3086
- Email: PCRC-NCORP@Swedish.org
-
Principal Investigator:
- Nitya Alluri
-
Seattle, Washington, United States, 98107
- Recruiting
- Swedish Medical Center-Ballard Campus
-
Contact:
- Site Public Contact
- Phone Number: 206-215-3086
- Email: PCRC-NCORP@Swedish.org
-
Principal Investigator:
- Nitya Alluri
-
Vancouver, Washington, United States, 98686
- Recruiting
- Legacy Salmon Creek Hospital
-
Contact:
- Site Public Contact
- Phone Number: 503-413-2150
-
Principal Investigator:
- Andrew Y. Kee
-
Vancouver, Washington, United States, 98684
- Recruiting
- Legacy Cancer Institute Medical Oncology and Day Treatment
-
Contact:
- Site Public Contact
- Email: oncologyresearch@lhs.org
-
Principal Investigator:
- Andrew Y. Kee
-
-
Wisconsin
-
Antigo, Wisconsin, United States, 54409
- Recruiting
- Langlade Hospital and Cancer Center
-
Contact:
- Site Public Contact
- Phone Number: 715-623-9869
- Email: Juli.Alford@aspirus.org
-
Principal Investigator:
- Andrew J. Huang
-
Madison, Wisconsin, United States, 53792
- Recruiting
- University of Wisconsin Carbone Cancer Center
-
Principal Investigator:
- Bethany M. Anderson
-
Contact:
- Site Public Contact
- Phone Number: 800-622-8922
-
Menomonee Falls, Wisconsin, United States, 53051
- Recruiting
- Froedtert Menomonee Falls Hospital
-
Principal Investigator:
- Adam D. Currey
-
Contact:
- Site Public Contact
- Phone Number: 262-257-5100
-
Milwaukee, Wisconsin, United States, 53226
- Recruiting
- Medical College of Wisconsin
-
Principal Investigator:
- Adam D. Currey
-
Contact:
- Site Public Contact
- Phone Number: 414-805-3666
-
Mukwonago, Wisconsin, United States, 53149
- Recruiting
- ProHealth D N Greenwald Center
-
Contact:
- Site Public Contact
- Email: research.institute@phci.org
-
Principal Investigator:
- Timothy R. Wassenaar
-
Oak Creek, Wisconsin, United States, 53154
- Recruiting
- Drexel Town Square Health Center
-
Principal Investigator:
- Adam D. Currey
-
Contact:
- Site Public Contact
- Phone Number: 414-805-0505
-
Oconomowoc, Wisconsin, United States, 53066
- Recruiting
- ProHealth Oconomowoc Memorial Hospital
-
Principal Investigator:
- Timothy R. Wassenaar
-
Contact:
- Site Public Contact
- Phone Number: 262-928-7878
-
Rhinelander, Wisconsin, United States, 54501
- Recruiting
- Ascension Saint Mary's Hospital
-
Principal Investigator:
- Andrew J. Huang
-
Contact:
- Site Public Contact
- Phone Number: 715-847-2353
- Email: Beth.Knetter@aspirus.org
-
Stevens Point, Wisconsin, United States, 54481
- Recruiting
- Ascension Saint Michael's Hospital
-
Principal Investigator:
- Andrew J. Huang
-
Contact:
- Site Public Contact
- Phone Number: 715-847-2353
- Email: Beth.Knetter@aspirus.org
-
Waukesha, Wisconsin, United States, 53188
- Recruiting
- UW Cancer Center at ProHealth Care
-
Principal Investigator:
- Timothy R. Wassenaar
-
Contact:
- Site Public Contact
- Phone Number: 262-928-5539
- Email: Chanda.miller@phci.org
-
Wausau, Wisconsin, United States, 54401
- Recruiting
- Aspirus Regional Cancer Center
-
Principal Investigator:
- Andrew J. Huang
-
Contact:
- Site Public Contact
- Phone Number: 877-405-6866
-
West Bend, Wisconsin, United States, 53095
- Recruiting
- Froedtert West Bend Hospital/Kraemer Cancer Center
-
Principal Investigator:
- Adam D. Currey
-
Contact:
- Site Public Contact
- Phone Number: 414-805-0505
-
Wisconsin Rapids, Wisconsin, United States, 54494
- Recruiting
- Aspirus Cancer Care - Wisconsin Rapids
-
Principal Investigator:
- Andrew J. Huang
-
Contact:
- Site Public Contact
- Phone Number: 715-422-7718
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the U.S., authorization permitting release of personal health information.
female and male patients who have undergone breast conserving surgery and completed a minimum of 4 cycles (12 weeks) of neoadjuvant or adjuvant chemotherapy in combination with HER2-targeted therapy.
-≥ 40 years of age
- ECOG performance status of 0 ,1, or 2/Karnofsky performance status above 60
- Histologically or cytologically confirmed invasive breast carcinoma.
- tumor must have been determined to be HER2-positive by current ASCO/CAP guidelines based on local testing results.
- Patient must have undergone axillary staging, either sentinel node biopsy (SNB) or axillary lymph nodal dissection (ALND). In neoadjuvant patients, SNB following neoadjuvant therapy is strongly recommended. SNB prior to neoadjuvant therapy is discouraged, but patients are permitted if node negative (pN0).
- The following staging criteria must be met according to AJCC 8th edition criteria:
Adjuvant cohort : By pathologic evaluation, the patient's primary tumor must be </= 2 cm and ipsilateral nodes must be pN0. Surgical lumpectomy margins must be negative for invasive cancer and ductal carcinoma in situ (no ink on tumor).
Neoadjuvant cohort: Prior to neoadjuvant therapy, the patient's primary tumor must be < 3 cm by imaging studies, with negative axillary nodes (cN0) based on axillary U/S, CT, PET or MRI. Physical examination is not sufficient documentation of cN0 status; • Must be ypT0N0 at surgery (lumpectomy); patients with residual non-invasive disease (DCIS) in the surgical specimen (ypTis), are NOT eligible.
- For the Adjuvant cohort, adjuvant therapy must have consisted of a minimum of 4 cycles (12 weeks) of chemotherapy in combination with HER2-targeted therapy.
- For the Neoadjuvant cohort, neoadjuvant therapy must have consisted of a minimum of 4 cycles (12 weeks) of chemotherapy in combination with HER2-targeted therapy.- ; Patients who did not receive chemotherapy in the neoadjuvant setting are not eligible, even if they achieved pCR with their preoperative treatment; nor would these patients become eligible by receiving chemotherapy after surgery.
- In patients assigned to radiation therapy, treatment should start ≤ 12 weeks from surgery on the Neoadjuvant cohort and ≤ 8 weeks from the completion of chemotherapy on the Adjuvant cohort. Patients should continue HER2-targeted therapy during assigned study treatment (radiation or observation).
- Bilateral mammogram or MRI within 52 weeks prior to randomization.
- HIV-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization are eligible for this trial.
Exclusion Criteria:
- Definitive clinical or radiologic evidence of metastatic disease.
- On the Adjuvant cohort, patients with a primary tumor >2 cm on pathologic examination of the surgical specimen. On the Neoadjuvant cohort, patients with a primary tumor > 3 cm or with abnormal or suspicious ipsilateral axillary nodes by pretreatment imaging, unless demonstrated to be negative by cytologic or histologic examination.
- Pathologically positive axillary nodes at any time including of pN0(i+) or pN0(mol+) ypN0(i+) or ypN0(mol+) disease.
- Patient planning for or status-post mastectomy.
- Radiographically suspicious ipsilateral or contralateral axillary, supraclavicular, infraclavicular, or internal mammary lymph nodes, unless there is histological confirmation that these nodes are negative for metastatic disease.
- Suspicious microcalcifications, densities, or palpable abnormalities (in the ipsilateral or contralateral breast), or mass or non-mass enhancement on MRI (if performed) aside from the known cancer, unless biopsied and found to be benign.
- Non-epithelial breast malignancies such as sarcoma or lymphoma.
- Multicentric carcinoma (invasive cancer or DCIS) in more than one quadrant or separated by > 4 centimeters. If multifocal, all foci should be confined to a maximum tumor bed of 3 cm determined by pathological assessment.
- Paget's disease of the nipple.
- Synchronous (unilateral or bilateral) invasive breast cancer or DCIS. (Patients with synchronous and/or previous contralateral LCIS are eligible.)
- On the Adjuvant cohort, surgical margins that cannot be microscopically assessed or are positive at pathologic evaluation. (If surgical margins are rendered free of disease by re-excision, the patient is eligible).
- Treatment plan that includes regional nodal irradiation.
- Patients treated for a prior invasive breast malignancy are excluded. Contralateral DCIS ≥ 10 years prior to enrollment is permissible.
- Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial.
- Patients on oral, transdermal, or subdermal estrogen replacement (including all estrogen only and estrogen-progesterone formulas) are not eligible unless discontinued prior to randomization.
- Prior ipsilateral breast or thoracic RT for any condition (contralateral RT for DCIS ≥ 10 years prior to randomization is permitted).
- Active collagen vascular disease, specifically dermatomyositis with a CPK level above normal or with an active systemic lupus erythematosus, or scleroderma.
- Clinicians should consider whether any conditions would make this protocol unreasonably hazardous for the patient.
- Pregnancy or lactation at the time of randomization or intention to become pregnant during treatment. (Note: Pregnancy testing according to institutional standards for patients of childbearing potential must be performed within 14 days prior to randomization.)
- Use of any investigational product within 30 days prior to randomization.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard of Care Adjuvant Breast Radiation
Patients continue to receive their current planned adjuvant breast radiation and systemic HER2-targeted therapies
|
adjuvant breast radiotherapy per the current standard of care
|
Active Comparator: Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
Patients continue to receive their current systemic HER2-targeted therapy without breast adjuvant radiation
|
participants are randomized to continue their standard of care systemic HER2-targeted therapy without adjuvant breast radiotherapy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
recurrence-free interval (RFI)
Time Frame: From randomization to first recurrence event or censoring for the duration of the trial, at 10.5 years
|
Time to recurrence event or censoring
|
From randomization to first recurrence event or censoring for the duration of the trial, at 10.5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ipsilateral breast recurrence (IBR) for radiation omitting arm
Time Frame: From randomization to first recurrence event or censoring for the duration of the trial , measured at year 7
|
Time to IBTR event or censoring
|
From randomization to first recurrence event or censoring for the duration of the trial , measured at year 7
|
ipsilateral breast recurrence (IBR) by treatment arm
Time Frame: From randomization to first recurrence event or censoring for the duration of the trial at 10.5 years.
|
Time to ipsilateral breast recurrence (IBR) by treatment arm.
|
From randomization to first recurrence event or censoring for the duration of the trial at 10.5 years.
|
local regional recurrence (LRR) by treatment arm
Time Frame: From randomization to first recurrence event or censoring for the duration of the trial at 10.5 years.
|
Time to local regional recurrence (LRR) by treatment arm.
|
From randomization to first recurrence event or censoring for the duration of the trial at 10.5 years.
|
disease-free survival (DFS) by treatment arm.
Time Frame: From the time of randomization for the duration of the trial at 10.5 years.
|
To determine disease-free survival (DFS) by treatment arm.
|
From the time of randomization for the duration of the trial at 10.5 years.
|
overall survival (OS) by treatment arm.
Time Frame: From the time of randomization for the duration of the trial at 10.5 years.
|
To determine overall survival (OS) by treatment arm.
|
From the time of randomization for the duration of the trial at 10.5 years.
|
patient-reported breast pain by treatment arm using the Breast Cancer Treatment Outcome Scale (BCTOS)
Time Frame: At 3 years after randomization
|
To evaluate whether there is a difference in patient-reported breast pain in patients who do and do not receive breast radiation in cohort A and cohort B. The BCTOS pain score has a range from 1-5 with higher scores indicating worse pain.
|
At 3 years after randomization
|
patient-reported worry about recurrence by treatment arm using a the three-item worry about recurrence score
Time Frame: At 3 years after randomization
|
To evaluate whether there is a difference in patient-reported worry about recurrence in patients who do and do not receive breast radiation in cohort A and cohort B. The worry about recurrence score has a range from 1-5 with higher scores indicating more worry.
|
At 3 years after randomization
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Norman Wolmark, MD, NRG Oncology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NRG-BR008
- 5U10CA180868 (U.S. NIH Grant/Contract)
- NCI-2022-09157 (Other Identifier: NCI)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HER2-positive Breast Cancer
-
Mersana TherapeuticsRecruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Non-Small Cell Lung Cancer | HER2-positive Colorectal Cancer | HER2-positive Tumors | HER2 Low Breast CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
MacroGenicsApproved for marketingHER2-positive Breast Cancer | HER2-positive Carcinoma
-
Spanish Breast Cancer Research GroupSeagen Inc.RecruitingHER2-positive Metastatic Breast Cancer | Locally Advanced HER2 Positive Breast CarcinomaSpain
-
Cancer Trials IrelandCompletedBreast Cancer | HER2 Positive Breast Cancer | HER2 Negative Breast CancerIreland
-
Enliven TherapeuticsRecruitingColorectal Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2 Amplification | HER2 Positive Solid TumorsUnited States
-
University of ArizonaPfizerCompletedBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | Recurrent Breast Cancer | HER2 Positive Breast Carcinoma | Breast Cancer StageUnited States
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Clovis Oncology, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | Estrogen Receptor Positive | Triple Negative | HER2 | HER2 Positive | MBC | ERUnited States
-
Ruth O'ReganUniversity of Rochester; Puma Biotechnology, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast CancerUnited States
Clinical Trials on Standard of Care Adjuvant Breast Radiation
-
Sunnybrook Health Sciences CentreBritish Columbia Cancer AgencyUnknown
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Radiation Therapy Oncology Group; North Central... and other collaboratorsCompleted
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingAnatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Localized Breast CarcinomaUnited States
-
Sheba Medical CenterTechnion, Israel Institute of TechnologyCompleted
-
Chang Gung Memorial HospitalRecruiting
-
Alice ChungNot yet recruitingBreast Cancer | Mastectomy; Lymphedema | Female Breast Cancer | Axilla; Breast | Tumor, Breast | Axillary Nodal Disease
-
Instituto Brasileiro de Controle do CancerRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast Cancer | Breast Cancer Female | Breast AdenocarcinomaUnited States
-
Technical University of MunichGerman Cancer AidRecruitingBreast Cancer | Radiotherapy | Relaxation | BreathholdingGermany
-
UNICANCERActive, not recruitingBreast Cancer | LumpectomyFrance